Madrigal Pharmaceuticals, Inc.
Key Metrics
- Previous Close
- $421.99
- 52-Week Range
- $353.54 – $615.00
- Market Cap
- $9.25B
- P/E (TTM)
- —
- EPS (TTM)
- -5.85
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 14.74
- PEG Ratio
- —
- Return on Equity
- -24.82%
- Return on Assets
- -6.82%
- Gross Margin
- 90.96%
- Operating Margin
- -10.69%
- Profit Margin
- -10.89%
- Current Ratio
- 3.05
- Debt/Equity
- 0.56
- Total Debt
- $354.22M
- Free Cash Flow
- $-112.43M
- Revenue Growth
- 50.10%
- Earnings Growth
- —
- Enterprise Value
- $8.64B
Market Snapshot
About
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics for liver diseases, including non-alcoholic steatohepatitis (NASH/MASH) and related metabolic disorders.